Colorectal cancer population screening programs worldwide in 2016: An update

World Journal of Gastroenterology

Volumn 23, Issue 20, 2017, Pages 3632-3642

  Navarro, Mercedes ^a   Nicolas, Andrea ^b   Ferrandez, Angel ^a   Lanas, Angel ^a,b,c,d  

^a HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

^b UNIVERSITY OF ZARAGOZA   (Spain)

^c INSTITUTO ARAGONÉS DE CIENCIAS DE LA SALUD   (Spain)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Colonoscopy; Colorectal cancer; Colorectal cancer screening; Fecal immunochemical test; Fecal occult blood test

Indexed keywords

AUSTRALIA; CANADA; CANCER MORTALITY; CANCER SCREENING; CHILE; COLONOSCOPY; COLORECTAL CANCER; CROATIA; CZECH REPUBLIC; ENGLAND; EUROPE; FECAL IMMUNOCHEMICAL TEST; FECES ANALYSIS; FRANCE; HUMAN; IMMUNOCHEMISTRY; IRELAND; ITALY; JAPAN; LITHUANIA; NETHERLANDS; OCCULT BLOOD; PATIENT PARTICIPATION; PRACTICE GUIDELINE; REVIEW; SEX DIFFERENCE; SIGMOIDOSCOPY; SLOVENIA; SOUTH KOREA; SPAIN; TAIWAN; THAILAND; UNITED STATES; ADULT; AGED; COLORECTAL TUMOR; EARLY CANCER DIAGNOSIS; FECES; FEMALE; GEOGRAPHY; GLOBAL HEALTH; INCIDENCE; MALE; MASS SCREENING; MIDDLE AGED; MORTALITY; PROCEDURES;

ADULT; AGED; CANADA; COLONOSCOPY; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FECES; FEMALE; GEOGRAPHY; GLOBAL HEALTH; HUMANS; IMMUNOCHEMISTRY; INCIDENCE; MALE; MASS SCREENING; MIDDLE AGED; NETHERLANDS; OCCULT BLOOD;

EID: 85019747478     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v23.i20.3632     Document Type: Review

References (56)

1. Globocan. Estimated cancer incidence, mortality and prevalence worldwide in 2012. (2012). Avaiable from: URL: http://globocan. iarc.fr/Default.aspx
2. Forman D, Bray F, Brewster DH, Gombe Mbalawa C, Kohler B, Piñeros M, Steliarova-Foucher E, Swaminathan R, Ferlay J. Cancer incidence in five continents. Vol X. International Agency for Research on Cancer, 2014
3. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127: 2893-2917 [PMID: 21351269 DOI: 10.1002/ijc.25516]
4. Schreuders EH, Ruco A, Rabeneck L, Schoen RE, Sung JJ, Young GP, Kuipers EJ. Colorectal cancer screening: a global overview of existing programmes. Gut 2015; 64: 1637-1649 [PMID: 26041752 DOI: 10.1136/gutjnl-2014-309086]
5. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin 2016; 66: 7-30 [PMID: 26742998 DOI: 10.3322/caac.21332]
6. Winawer SJ, Zauber AG, Ho MN, O'Brien MJ, Gottlieb LS, Sternberg SS, Waye JD, Schapiro M, Bond JH, Panish JF. Pr event ion of colorectal cancer by colonos copic polypectomy. The National Polyp Study Workgroup. N Engl J Med 1993; 329: 1977-1981 [PMID: 8247072 DOI: 10.1056/NEJM199312303292701]
7. Stryker SJ, Wolff BG, Culp CE, Libbe SD, Ilstrup DM, MacCarty RL. Natural history of untreated colonic polyps. Gastroenterology 1987; 93: 1009-1013 [PMID: 3653628]
8. Wilson JMG, Jungner G. Principles and practice of screening for disease. Geneva: WHO; 1968. Available from: URL: http://www.who.int/bulletin/volumes/86/4/07-050112BP.pdf
9. Andermann A, Blancquaert I, Beauchamp S, Déry V. Revisiting Wilson and Jungner in the genomic age: a review of screening criteria over the past 40 years. Bull World Health Organ 2008; 86: 317-319 [PMID: 18438522 DOI: 10.2471/BLT.07.050112]
10. Pignone M, Saha S, Hoerger T, Mandelblatt J. Cost-effectiveness analyses of colorectal cancer screening: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 2002; 137: 96-104 [PMID: 12118964 DOI: 10.7326/0003-4819-137-2-200207 160-00007]
11. Castells A, Marzo-Castillejo M, Mascort J, Amador F, Andreu M, Bellas B. Guía de práctica clínica en prevención del cáncer colorectal. Gastroenterol Hepatol 2009; 32: 717.e1-717.e58 [DOI: 10.1016/j.gastrohep.2009.09.001]
12. Hewitson P, Glasziou P, Watson E, Towler B, Irwig L. Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update. Am J Gastroenterol 2008; 103: 1541-1549 [PMID: 18479499 DOI: 10.1111/j.1572-0241.2008.01875.x]
13. Shaukat A, Mongin SJ, Geisser MS, Lederle FA, Bond JH, Mandel JS, Church TR. Long-term mortality after screening for colorectal cancer. N Engl J Med 2013; 369: 1106-1114 [PMID: 24047060 DOI: 10.1056/NEJMoa1300720]
14. Mandel JS, Church TR, Bond JH, Ederer F, Geisser MS, Mongin SJ, Snover DC, Schuman LM. The effect of fecal occultblood screening on the incidence of colorectal cancer. N Engl J Med 2000; 343: 1603-1607 [PMID: 11096167 DOI: 10.1056/NEJM200011303432203]
15. van Rossum LG, van Rijn AF, Laheij RJ, van Oijen MG, Fockens P, van Krieken HH, Verbeek AL, Jansen JB, Dekker E. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology 2008; 135: 82-90 [PMID: 18482589 DOI: 10.1053/j.gastro.2008.03.040]
16. Parra-Blanco A, Gimeno-García AZ, Quintero E, Nicolás D, Moreno SG, Jiménez A, Hernández-Guerra M, Carrillo-Palau M, Eishi Y, López-Bastida J. Diagnostic accuracy of immunochemical versus guaiac faecal occult blood tests for colorectal cancer screening. J Gastroenterol 2010; 45: 703-712 [PMID: 20157748 DOI: 10.1007/s00535-010-0214-8]
17. Grazzini G, Visioli CB, Zorzi M, Ciatto S, Banovich F, Bonanomi AG, Bortoli A, Castiglione G, Cazzola L, Confortini M, Mantellini P, Rubeca T, Zappa M. Immunochemical faecal occult blood test: number of samples and positivity cutoff. What is the best strategy for colorectal cancer screening? Br J Cancer 2009; 100: 259-265 [PMID: 19142185 DOI: 10.1038/sj.bjc.6604864]
18. Hamza S, Dancourt V, Lejeune C, Bidan JM, Lepage C, Faivre J. Diagnostic yield of a one sample immunochemical test at different cut-off values in an organised screening programme for colorectal cancer. Eur J Cancer 2013; 49: 2727-2733 [PMID: 23601670 DOI: 10.1016/j.ejca.2013.03.023]
19. Tinmouth J, Lansdorp-Vogelaar I, Allison JE. Faecal immunochemical tests versus guaiac faecal occult blood tests: what clinicians and colorectal cancer screening programme organisers need to know. Gut 2015; 64: 1327-1337 [PMID: 26041750 DOI: 10.1136/gutjnl-2014-308074]
20. National Cancer Institute. Colorectal Cancer Prevention. Available from: URL: http://www.cancer.gov
21. Atkin WS, Edwards R, Kralj-Hans I, Wooldrage K, Hart AR, Northover JM, Parkin DM, Wardle J, Duffy SW, Cuzick J. Onceonly flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet 2010; 375: 1624-1633 [PMID: 20430429 DOI: 10.1016/S0140-6736(10)60551-X]
22. Brenner H, Stock C, Hoffmeister M. Effect of screening sigmoidoscopy and screening colonoscopy on colorectal cancer incidence and mortality: systematic review and meta-analysis of randomised controlled trials and observational studies. BMJ 2014; 348: g2467 [PMID: 24922745 DOI: 10.1136/bmj.g2467]
23. Zarchy TM, Ershoff D. Do characteristics of adenomas on flexible sigmoidoscopy predict advanced lesions on baseline colonoscopy? Gastroenterology 1994; 106: 1501-1504 [PMID: 8194695]
24. Papatheodoridis GV, Triantafyllou K, Tzouvala M, Paspatis G, Xourgias V, Karamanolis DG. Characteristics of rectosigmoid adenomas as predictors of synchronous advanced proximal colon neoplasms. Am J Gastroenterol 1996; 91: 1809-1813 [PMID: 8792703]
25. Brenner H, Chang-Claude J, Jansen L, Knebel P, Stock C, Hoffmeister M. Reduced risk of colorectal cancer up to 10 years after screening, surveillance, or diagnostic colonoscopy. Gastroenterology 2014; 146: 709-717 [PMID: 24012982 DOI: 10.1053/j.gastro.2013.09.001]
26. Kahi CJ, Imperiale TF, Juliar BE, Rex DK. Effect of screening colonoscopy on colorectal cancer incidence and mortality. Clin Gastroenterol Hepatol 2009; 7: 770-775; quiz 711 [PMID: 19268269 DOI: 10.1016/j.cgh.2008.12.030]
27. Citarda F, Tomaselli G, Capocaccia R, Barcherini S, Crespi M. Efficacy in standard clinical practice of colonoscopic polypectomy in reducing colorectal cancer incidence. Gut 2001; 48: 812-815 [PMID: 11358901 DOI: 10.1136/gut.48.6.812]
28. Smith RA, Andrews K, Brooks D, DeSantis CE, Fedewa SA, Lortet-Tieulent J, Manassaram-Baptiste D, Brawley OW, Wender RC. Cancer screening in the United States, 2016: A review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin 2016; 66: 96-114 [PMID: 26797525 DOI: 10.3322/caac.21336]
29. Rex DK, Schoenfeld PS, Cohen J, Pike IM, Adler DG, Fennerty MB, Lieb JG, Park WG, Rizk MK, Sawhney MS, Shaheen NJ, Wani S, Weinberg DS. Quality indicators for colonoscopy. Am J Gastroenterol 2015; 110: 72-90 [PMID: 25448873 DOI: 10.1038/ajg.2014.385]
30. Corley DA, Jensen CD, Marks AR, Zhao WK, Lee JK, Doubeni CA, Zauber AG, de Boer J, Fireman BH, Schottinger JE, Quinn VP, Ghai NR, Levin TR, Quesenberry CP. Adenoma detection rate and risk of colorectal cancer and death. N Engl J Med 2014; 370: 1298-1306 [PMID: 24693890 DOI: 10.1056/NEJMoa1309086]
31. Segnan N, Senore C, Andreoni B, Azzoni A, Bisanti L, Cardelli A, Castiglione G, Crosta C, Ederle A, Fantin A, Ferrari A, Fracchia M, Ferrero F, Gasperoni S, Recchia S, Risio M, Rubeca T, Saracco G, Zappa M. Comparing attendance and detection rate of colonoscopy with sigmoidoscopy and FIT for colorectal cancer screening. Gastroenterology 2007; 132: 2304-2312 [PMID: 17570205 DOI: 10.1053/j.gastro.2007.03.030]
32. Quintero E, Castells A, Bujanda L, Cubiella J, Salas D, Lanas Á, Andreu M, Carballo F, Morillas JD, Hernández C, Jover R, Montalvo I, Arenas J, Laredo E, Hernández V, Iglesias F, Cid E, Zubizarreta R, Sala T, Ponce M, Andrés M, Teruel G, Peris A, Roncales MP, Polo-Tomás M, Bessa X, Ferrer-Armengou O, Grau J, Serradesanferm A, Ono A, Cruzado J, Pérez-Riquelme F, Alonso-Abreu I, de la Vega-Prieto M, Reyes-Melian JM, Cacho G, Díaz-Tasende J, Herreros-de-Tejada A, Poves C, Santander C, González-Navarro A. Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening. N Engl J Med 2012; 366: 697-706 [PMID: 22356323 DOI: 10.1056/NEJMoa1108895]
33. Council of the European Union. Council Recommendation of 2 December 2003 on Cancer Screening (2003/878/EC) 878. Off J Eur Union, 2003
34. Red de programas de cribado de cáncer. Available from: URL: http://www.cribadocancer.com
35. Heijnen ML, Landsdorp-Vogelaar I. CRC Screening in the Netherlands. From pilot to National Programme. 2014. Available from: URL: http://www.rivm.nl/en/Topics/B/Bowel-cancer-screen ing-programme
36. McNamara D, Qasim A, Lee N, Condon C, O'Morain C. Round one of the Adelaide and Meath Hospital/Trinity College Colorectal Cancer Screening Programme: programme report and analysis based on established international key performance indices. Ir J Med Sci 2011; 180: 549-552 [PMID: 21264524 DOI: 10.1007/s11845-010-0650-8]
37. McNamara D, Leen R, Seng-Lee C, Shearer N, Crotty P, Neary P, Walsh P, Boran G, O'Morain C. Sustained participation, colonoscopy uptake and adenoma detection rates over two rounds of the Tallaght-Trinity College colorectal cancer screening programme with the faecal immunological test. Eur J Gastroenterol Hepatol 2014; 26: 1415-1421 [PMID: 25244415 DOI: 10.1097/MEG.0000000000000207]
38. Parente F, Boemo C, Ardizzoia A, Costa M, Carzaniga P, Ilardo A, Moretti R, Cremaschini M, Parente EM, Pirola ME. Outcomes and cost evaluation of the first two rounds of a colorectal cancer screening program based on immunochemical fecal occult blood test in northern Italy. Endoscopy 2013; 45: 27-34 [PMID: 23254404 DOI: 10.1055/s-0032-1325800]
39. Katicic M, Antoljak N, Kujundžić M, Stamenić V, Skoko Poljak D, Kramarić D, Stimac D, Strnad Pešikan M, Samija M, Ebling Z. Results of National Colorectal Cancer Screening Program in Croatia (2007-2011). World J Gastroenterol 2012; 18: 4300-4307 [PMID: 22969192 DOI: 10.3748/wjg.v18.i32.4300]
40. Poskus T, Strupas K, Mikalauskas S, Bitinaitė D, Kavaliauskas A, Samalavicius NE, Saladzinskas Z. Initial results of the National Colorectal Cancer Screening Program in Lithuania. Eur J Cancer Prev 2015; 24: 76-80 [PMID: 25370682 DOI: 10.1097/CEJ.0000000000000096]
41. SVIT Programme: Screening for colorectal Cancer. Republic of Slovenia. Ministry of health. Available from: URL: http://www.dpor.si
42. Logan RF, Patnick J, Nickerson C, Coleman L, Rutter MD, von Wagner C. Outcomes of the Bowel Cancer Screening Programme (BCSP) in England after the first 1 million tests. Gut 2012; 61: 1439-1446 [PMID: 22156981 DOI: 10.1136/gutjnl-2011-300843]
43. Suchanek S, Majek O, Vojtechova G, Minarikova P, Rotnaglova B, Seifert B, Minarik M, Kozeny P, Dusek L, Zavoral M. Colorectal cancer prevention in the Czech Republic: time trends in performance indicators and current situation after 10 years of screening. Eur J Cancer Prev 2014; 23: 18-26 [PMID: 24129196 DOI: 10.1097/CEJ.0b013e328364f203]
44. Leuraud K, Jezewski-Serra D, Viguier J, Salines E. Colorectal cancer screening by guaiac faecal occult blood test in France: Evaluation of the programme two years after launching. Cancer Epidemiol 2013; 37: 959-967 [PMID: 24035240 DOI: 10.1016/j.canep.2013.07.008]
45. Jensen CD, Corley DA, Quinn VP, Doubeni CA, Zauber AG, Lee JK, Zhao WK, Marks AR, Schottinger JE, Ghai NR, Lee AT, Contreras R, Klabunde CN, Quesenberry CP, Levin TR, Mysliwiec PA. Fecal Immunochemical Test Program Performance Over 4 Rounds of Annual Screening: A Retrospective Cohort Study. Ann Intern Med 2016; 164: 456-463 [PMID: 26811150 DOI: 10.7326/M15-0983]
46. Major D, Bryant H, Delaney M, Fekete S, Gentile L, Harrison M, Mai V, Nicholson E, Taylor Y. Colorectal cancer screening in Canada: results from the first round of screening for five provincial programs. Curr Oncol 2013; 20: 252-257 [PMID: 24155629 DOI: 10.3747/co.20.1646]
47. López-Kostner F, Kronberg U, Zarate AJ Cortés M. Programa de detección de neoplasias colorrectales en población mayor de 50 años. Rev Med Chile 2012; 140: 281-286 [DOI: 10.4067/S0034-9887201200030000]
48. Sung JJ, Ng SC, Chan FK, Chiu HM, Kim HS, Matsuda T, Ng SS, Lau JY, Zheng S, Adler S, Reddy N, Yeoh KG, Tsoi KK, Ching JY, Kuipers EJ, Rabeneck L, Young GP, Steele RJ, Lieberman D, Goh KL. An updated Asia Pacific Consensus Recommendations on colorectal cancer screening. Gut 2015; 64: 121-132 [PMID: 24647008 DOI: 10.1136/gutjnl-2013-306503]
49. Cai SR, Zhang SZ, Zhu HH, Zheng S. Barriers to colorectal cancer screening: a case-control study. World J Gastroenterol 2009; 15: 2531-2536 [PMID: 19469005 DOI: 10.3748/wjg.15.2531]
50. Sano Y, Byeon JS, Li XB, Wong MC, Chiu HM, Rerknimitr R, Utsumi T, Hattori S, Sano W, Iwatate M, Chiu P, Sung J. Colorectal cancer screening of the general population in East Asia. Dig Endosc 2016; 28: 243-249 [PMID: 26595883 DOI: 10.1111/den.12579]
51. Center for cancer control and information services NCC. Cancer statistics in Japan '13. Japan: foundation for promotion of cancer research, 2013. Available from: URL: http://www.ncc.go.jp/en/cis/index.html
52. Suh M, Song S, Cho HN, Park B, Jun JK, Choi E, Kim Y, Choi KS. Trends in Participation Rates for the National Cancer Screening Program in Korea, 2002-2012. Cancer Res Treat 2016; Epub ahead of print [PMID: 27857022 DOI: 10.4143/crt.2016.186]
53. Choi KS, Lee HY, Jun JK, Shin A, Park EC. Adherence to followup after a positive fecal occult blood test in an organized colorectal cancer screening program in Korea, 2004-2008. J Gastroenterol Hepatol 2012; 27: 1070-1077 [PMID: 22004224 DOI: 10.1111/j.1440-1746.2011.06944.x]
54. Chiu HM, Chen SL, Yen AM, Chiu SY, Fann JC, Lee YC, Pan SL, Wu MS, Liao CS, Chen HH, Koong SL, Chiou ST. Effectiveness of fecal immunochemical testing in reducing colorectal cancer mortality from the One Million Taiwanese Screening Program. Cancer 2015; 121: 3221-3229 [PMID: 25995082 DOI: 10.1002/cncr.29462]
55. Khuhaprema T, Sangrajrang S, Lalitwongsa S, Chokvanitphong V, Raunroadroong T, Ratanachu-Ek T, Muwonge R, Lucas E, Wild C, Sankaranarayanan R. Organised colorectal cancer screening in Lampang Province, Thailand: preliminary results from a pilot implementation programme. BMJ Open 2014; 4: e003671 [PMID: 24435889 DOI: 10.1136/bmjopen-2013-003671]
56. Commonwealth of Australia. The Australian bowel Cancer Screening Pilot Program and Beyond, 2005. Screening monograph no.6/2005. Available from: URL: http://www.cancerscreening.gov.au/internet/screening/publishing.nsf/content/9C0493AFEB3FD33CCA257D720005C9F2/$File/final-eval.pdf